Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
ceftazidime pentahydrate, Quantity: 1175 mg (Equivalent: ceftazidime, Qty 1000 mg)
Strides Pharma Science Pty Ltd
Ceftazidime
Injection, powder for
Excipient Ingredients: sodium carbonate
Intramuscular, Intravenous
1 vial
(S4) Prescription Only Medicine
Ceftazidime for Injection is indicated for the treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime, and as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other pseudomonal antibiotics cannot be used. ,Indications include the following:,Severe infections in general: ,For example: septicaemia including neonatal sepsis, bacteraemia; and in patients in intensive care units with specific problems, e.g., infected burns.,Respiratory tract infections: ,For example: pneumonia, broncho-pneumonia, infected pleurisy, infected bronchiectasis and bronchitis.,Severe ear, nose and throat infections: ,For example: otitis media, mastoiditis.,Urinary tract infections: ,For example: acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only), and infections associated with bladder and renal stones.,Skin and soft tissue infections: ,For example, erysipelas, abscesses, cellulitis, infected burns and wounds, mastitis.,Gastrointestinal and abdominal infections: ,For example: intra-abdominal abscesses, enterocolitis.,Bone and joint infections: ,For example: osteitis, osteomyelitis, septic arthritis, infected bursitis.
Visual Identification: White or pale yellow coloured powder filled in clear glass vials, stoppered with rubber stoppers & sealed with aluminium seal with orange PP disc; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius
Registered
2012-01-09
ZETAF 1G AND 2G CONSUMER MEDICINE INFORMATION Ver 1.2 ZETAF 1G & 2G Ceftazidime (as pentahydrate) CONSUMER MEDICINE INFORMATION _ _ ZETAF Page 1 of 3 WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ZETAF. It does not contain all the available information. It does not take the place of talking to your doctor and pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given ZETAF against the benefits this medicine is expected to have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET IN A SAFE PLACE. You may need to read it again. WHAT ZETAF IS USED FOR Ceftazidime is an antibiotic used to treat infections in different parts of the body caused by bacteria. Ceftazidime is also used to prevent infections before, during and after surgery. Ceftazidime will not work against infections caused by viruses such as colds or the flu. Ceftazidime belongs to a group of antibiotics called cephalosporins. These antibiotics work by killing the bacteria that are causing your infection. Your doctor may have prescribed ceftazidime for another reason. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY CEFTAZIDIME HAS BEEN PRESCRIBED FOR YOU. This medicine is available only with a doctor’s prescription. BEFORE YOU ARE GIVEN ZETAF WHEN YOU MUST NOT BE GIVEN IT ZETAF SHOULD NOT BE GIVEN TO YOU IF YOU HAVE AN ALLERGY TO: • ceftazidime • other cephalosporins • lignocaine • any of the ingredients listed at the end of this leaflet. Symptoms of an allergic reaction may include: • shortness of breath, wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin. CEFTAZIDIME SHOULD NOT BE GIVEN TO YOU IF YOU HAVE HAD A MAJOR ALLERGIC REACTION TO PENICILLINS. CEFTAZIDIME SHOULD NOT BE MIXED WITH LIGNOCAINE AND GIVEN TO YOU IF YOU HAVE HAD AN ALLERGIC REACTION TO LIGNOCAINE. Sometimes ceftazidime is mixed with lignocaine hydroch Olvassa el a teljes dokumentumot
Product Information: ZETAF 1g & 2g (Ceftazidime for Injection 1g & 2g) Ver 1.2 Page 1 of 11 PRODUCT INFORMATION ZETAF 1G (1G CEFTAZIDIME AS CEFTAZIDIME PENTAHYDRATE) ZETAF 2G (2G CEFTAZIDIME AS CEFTAZIDIME PENTAHYDRATE) NAME OF THE MEDICINE The name of medicine is Ceftazidime as Ceftazidime pentahydrate CHEMICAL NAME: (6R,7R)-7[[(2Z)-2-(2-Aminothiazol-4-yl)-2-[(1-carboxy-1-methylethoxy)imino] acetyl]amino]-8-oxo-3-[(1-pyridinio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate pentahydrate. MOLECULAR FORMULA: C 22 H 22 N 6 O 7 S 2 .5H 2 0 CAS REGISTRY NUMBER: 72558-82-8 MOLECULAR WEIGHT : 636.6 DESCRIPTION ZETAF is a cephalosporin antibiotic for use by injection only. It is supplied as a white or almost white, crystalline powder in vials containing 1 g and 2 g ceftazidime (as pentahydrate) with sodium carbonate anhydrous (118 mg per gram of ceftazidime). On the addition of Water for Injections, ZETAF dissolves with effervescence to produce a clear, colourless solution for injection. ZETAF contains approximately 51 mg (2.2 mEq) of sodium per gram of ceftazidime. 116 mg ceftazidime pentahydrate is equivalent to 100 mg ceftazidime anhydrous. For laboratory tests associated with ceftazidime administration, ceftazidime pentahydrate should be used. PHARMACOLOGY MICROBIOLOGY Ceftazidime is bactericidal in action, exerting its effect on target cell wall proteins and causing inhibition of cell wall synthesis. It is stable to most beta-lactamases produced by Gram-positive and Gram-negative organisms and consequently is active against many ampicillin- and cephalothin- resistant strains (but not methicillin-resistant strains). Ceftazidime has been shown to have _in vitro _ activity against the following organisms: _ _ Product Information: ZETAF 1g & 2g (Ceftazidime for Injection 1g & 2g) Ver 1.2 Page 2 of 11 _GRAM-NEGATIVE: _ _Pseudomonas aeruginosa _ Pseudomonas species (other) _Klebsiella pneumoniae _ Klebsiella species (other) _Proteus mirabilis _ _Proteus vulgaris _ _Morganella morganii _ (formerly _Proteus morga Olvassa el a teljes dokumentumot